CV Sciences, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CV Sciences, Inc. (CVSI) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-26
- CV Sciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$200.00K.
- CV Sciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$3.40M.
- CV Sciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$700.00K, a 275.00% decline from fiscal 2022.
- CV Sciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $400.00K, a 85.19% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$200.00K 10-K · filed 2026-03-26 | |
| 2024-12-31 | -$3.40M 10-K · filed 2026-03-26 | |
| 2023-12-31 | -$700.00K 10-K · filed 2025-03-27 | |
| 2022-12-31 | $400.00K 10-K · filed 2024-03-29 | |
| 2021-12-31 | $2.70M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $4.60M 10-K · filed 2022-04-04 | |
| 2019-12-31 | $3.70M 10-K · filed 2021-03-19 | |
| 2018-12-31 | -$600.00K 10-K · filed 2020-03-30 | $586.00K 10-K · filed 2019-03-12 |
| 2017-12-31 | -$2.49M 10-K · filed 2019-03-12 | -$2.49M 10-K · filed 2018-03-30 |
| 2016-12-31 | $4.84M 10-K · filed 2018-03-30 | |
| 2015-12-31 | $2.62M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $549.77K 10-K · filed 2016-04-14 |